A blood RNA signature for tuberculosis disease risk: a prospective cohort study

Daniel E. Zak(Center for Infectious Disease Research), Adam Penn‐Nicholson(University of Cape Town), Thomas J. Scriba(University of Cape Town), Ethan Thompson(Center for Infectious Disease Research), Sara Suliman(University of Cape Town), Lynn M. Amon(Center for Infectious Disease Research), Hassan Mahomed(University of Cape Town), Mzwandile Erasmus(University of Cape Town), Wendy Whatney(University of Cape Town), Gregory Hussey(University of Cape Town), Deborah Abrahams(University of Cape Town), Fazlin Kafaar(University of Cape Town), Tony Hawkridge(University of Cape Town), Suzanne Verver(TuBerculosis Vaccine Initiative), E. Jane Hughes(University of Cape Town), Martin O. C. Ota(MRC Unit the Gambia), Jayne S. Sutherland(MRC Unit the Gambia), Rawleigh Howe(Armauer Hansen Research Institute), Hazel M. Dockrell(London School of Hygiene & Tropical Medicine), W. Henry Boom(Case Western Reserve University), Bonnie Thiel(Case Western Reserve University), Tom H. M. Ottenhoff(Leiden University Medical Center), Harriet Mayanja‐Kizza(Makerere University), Amelia C. Crampin(London School of Hygiene & Tropical Medicine), Katrina Downing(University of Cape Town), Mark Hatherill(University of Cape Town), Joe Valvo(Center for Infectious Disease Research), Smitha Shankar(Center for Infectious Disease Research), Shreemanta K. Parida(Max Planck Institute for Infection Biology), Stefan H. E. Kaufmann(Max Planck Institute for Infection Biology), Gerhard Walzl(Stellenbosch University), Alan Aderem(Center for Infectious Disease Research), Willem A. Hanekom(University of Cape Town)
The Lancet
March 24, 2016
Cited by 814Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis